Omnicell

Omnicell

Yahoo Finance • 2 days ago

OMCL Q3 deep dive: disciplined cost control offsets flat sales, software transition in early innings

OMCL Q3 deep dive: disciplined cost control offsets flat sales, software transition in early innings Healthcare tech company Omnicell (NASDAQ:OMCL) reported revenue ahead of Wall Street's expectations in Q3 2026, but sales were flat year... Full story

Yahoo Finance • 6 days ago

Omnicell anticipates $1.225B-$1.231B 2026 revenue while raising non-GAAP EBITDA to $187M-$193M

Earnings Call Insights: Omnicell (OMCL) Q3 2026 MANAGEMENT VIEW * "In the third quarter 2026, we delivered another quarter of strong execution. Total revenue was $308 million and non-GAAP EBITDA was $45 million, both above the high end... Full story

Yahoo Finance • 7 days ago

Omnicell (NASDAQ:OMCL) exceeds Q3 2026 expectations but quarterly revenue guidance misses expectations

Omnicell (NASDAQ:OMCL) exceeds Q3 2026 expectations but quarterly revenue guidance misses expectations Healthcare tech company Omnicell (NASDAQ:OMCL) announced better-than-expected revenue in Q3 2026, but revenue was flat year on year at... Full story

Yahoo Finance • 7 days ago

Omnicell: Q3 Earnings Snapshot

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported third-quarter earnings of $11 million. On a per-share basis, the Fort Worth, Texas-based company said it had profit of 24 cents. Earnings, adjuste... Full story

Yahoo Finance • 30 days ago

1 Healthcare Stock with Exciting Potential and 2 We Find Risky

1 Healthcare Stock with Exciting Potential and 2 We Find Risky Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks... Full story

Yahoo Finance • last month

3 Reasons OMCL is Risky and 1 Stock to Buy Instead

3 Reasons OMCL is Risky and 1 Stock to Buy Instead Omnicell has been treading water for the past six months, recording a small loss of 4.6% while holding steady at $32.74. The stock also fell short of the S&P 500's 16.4% gain during that... Full story

Yahoo Finance • 3 months ago

Omnicell President Sells 6,753 Shares

President & COO Nnamdi Njoku reported a sale of 6,753 shares of Omnicell, Inc. (NASDAQ:OMCL) at ~$37.09 per share on August 15, 2026, and August 17, 2026, according to a SEC Form 4 filing. Transaction summary Metric Value Transaction val... Full story

Yahoo Finance • 3 months ago

Omnicell forecasts 2026 non-GAAP EPS of $2.15-$2.30 while widening product bookings range to $425M-$560M

Earnings Call Insights: Omnicell (OMCL) Q2 2026 MANAGEMENT VIEW * "We delivered solid execution in the second quarter with results at or above our expectations across key financial metrics" (Founder, Executive Chairman & CEO Randall Li... Full story

Yahoo Finance • 4 months ago

1 Healthcare Stock to Target This Week and 2 We Brush Off

1 Healthcare Stock to Target This Week and 2 We Brush Off Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have... Full story

Yahoo Finance • 5 months ago

3 Healthcare Stocks We Think Twice About

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped... Full story

Yahoo Finance • 5 months ago

Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) and its peers. The healthcare technology... Full story

Yahoo Finance • 6 months ago

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

Omnicell’s 23% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $43.73 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating thei... Full story

Yahoo Finance • 6 months ago

Here is What Analysts Are Saying About Omnicell, Inc. (OMCL)

Omnicell, Inc. (NASDAQ:OMCL) is one of the best small cap stocks to buy for 10x potential. Omnicell, Inc. (NASDAQ:OMCL) received several rating updates following the release of its financial results for fiscal Q1 2026 on April 28. Craig-Ha... Full story

Yahoo Finance • 6 months ago

Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing

Key Points Avory & Company, LLC sold 156,571 shares of Omnicell; estimated trade value was $6.55 million based on quarterly average pricing The quarter-end value of the Omnicell position fell by $8.01 million, reflecting both the share sa... Full story

Yahoo Finance • 6 months ago

Smart Pill Dispenser Market Forecast Report 2025-2031: Omnicell, Capsa Healthcare and Becton Dickinson Strengthen Home Care Medication Management Market with Institutional and Delivery Expertise

Company Logo The smart pill dispenser market offers growth opportunities driven by technological advancements, IoT connectivity, and healthcare integration. Key opportunities include enhancing medication adherence, reducing costs from non... Full story

Yahoo Finance • 7 months ago

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 8 months ago

Omnicell, Inc. (OMCL): A Bull Case Theory

We came across a bullish thesis on Omnicell, Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on OMCL. Omnicell, Inc.'s share was trading at $38.61 as of February 18th. OMCL’s trailing P/E was 9... Full story

Yahoo Finance • 11 months ago

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise FORT WORTH, Texas, December 08, 2025--(BUSINESS WIRE)--Omnicell, Inc.... Full story

Yahoo Finance • 11 months ago

Medication Adherence Research Report 2025: Market to Reach $3.63 Billion by 2030, Driven by Rising Chronic Disease Burden, Aging Populations, and Growing Adoption of Digital Health Tools

Company Logo The Global Medication Adherence Market presents opportunities driven by the rising prevalence of chronic diseases, an aging population, and healthcare tech advances, notably AI integration. Challenges include high medication... Full story

Yahoo Finance • last year

Omnicell outlines raised 2025 revenue guidance to $1.177B-$1.187B as cloud platform gains traction

Earnings Call Insights: Omnicell (OMCL) Q3 2025 MANAGEMENT VIEW * Randall Lipps, Founder, Executive Chairman, President & CEO, announced "another strong quarter" for Omnicell, highlighting that "total revenues, non-GAAP EBITDA and non-... Full story